article thumbnail

Rare genetic variants linked to bicuspid aortic valve disease in young adults identified

Medical Xpress - Cardiology

Genetic variants linked to a rare form of bicuspid aortic valve disease that affects young adults and can lead to dangerous and potentially life-threatening aortic complications have been identified by researchers at UTHealth Houston.

article thumbnail

Columbia Cardiology Launches New Mitral & Tricuspid Center

DAIC

Columbia University Irving Medical Center’s Division of Cardiology has announced its launch of the Mitral & Tricuspid Center. Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure.

Tricuspid 111
article thumbnail

Spotlight on Advancements in Mitral Valve Repair, Research

DAIC

Barr’s death at 39 from sudden cardiac arrest was caused by mitral valve prolapse—a heart valve defect that can affect the heart’s ability to pump blood. In the past, heart surgeons corrected a faulty mitral valve by replacing it with an artificial one during open-heart surgery. It can, in some cases, lead to death.

article thumbnail

SGLT2i for Mitral Regurgitation; Mining Angiograms With AI; Melatonin and CVD Risk?

Med Page Today

Mashable) The SGLT2 inhibitor ertugliflozin (Steglatro) showed promise for the reduction of functional mitral. (MedPage Today) -- The Apple Watch atrial fibrillation feature got added to FDA's list of qualified devices for use in clinical studies.

article thumbnail

HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation

DAIC

milla1cf Mon, 06/03/2024 - 12:36 June 3, 2024 — HighLife SAS , a medtech company focused on the development of a novel Trans-Septal Mitral Valve Replacement (“TSMVR”) system to treat patients suffering from moderate to severe Mitral Regurgitation (MR), announced today that the U.S. I am honored to lead the HighLife pivotal study.

article thumbnail

SS Innovations’ SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement

DAIC

a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced that surgeons have successfully performed the world’s first mitral valve replacement using the Made in India, SSi Mantra Surgical Robotic System. from 2022 to 2031.

article thumbnail

4C Medical's AltaValve System Secures Dual FDA Breakthrough Device Designations, Expediting Patient Access to Advanced Mitral Valve Therapies

DAIC

Food and Drug Administratio n ( FDA ) for the AltaValve System , a transcatheter mitral valve replacement (TMVR) device. MR occurs when blood flows backward through the mitral valve and into the atrium each time the left ventricle contracts. milla1cf Wed, 05/08/2024 - 11:02 May 8, 2024 — 4C Medical Technologies, Inc. ("4C